108 related articles for article (PubMed ID: 10197806)
21. Treatment of relapsed acute lymphoblastic leukemia after allogeneic bone marrow transplantation with chemotherapy followed by G-CSF-primed donor leukocyte infusion: a prospective study.
Choi SJ; Lee JH; Lee JH; Kim S; Lee YS; Seol M; Ryu SG; Lee JS; Kim WK; Jang S; Park CJ; Chi HS; Lee KH
Bone Marrow Transplant; 2005 Jul; 36(2):163-9. PubMed ID: 15937507
[TBL] [Abstract][Full Text] [Related]
22. Randomized study of recombinant interleukin-2 after autologous bone marrow transplantation for acute leukemia in first complete remission.
Blaise D; Attal M; Reiffers J; Michallet M; Bellanger C; Pico JL; Stoppa AM; Payen C; Marit G; Bouabdallah R; Sotto JJ; Rossi JF; Brandely M; Hercend T; Maraninchi D
Eur Cytokine Netw; 2000 Mar; 11(1):91-8. PubMed ID: 10705305
[TBL] [Abstract][Full Text] [Related]
23. Antileukemic effect of interleukin-2-transduced murine bone marrow after autologous transplantation.
Tam YK; Klingemann HG
Biol Blood Marrow Transplant; 1999; 5(4):231-42. PubMed ID: 10465103
[TBL] [Abstract][Full Text] [Related]
24. Chemotherapy and donor peripheral blood progenitor cells for acute leukemia in early relapse after allogeneic bone marrow transplantation.
Alessandrino EP; Bernasconi P; Caldera D; Colombo A; Malcovati L; Martinelli G; Bonfichi M; Pagnucco G; Salvaneschi L; Bernasconi C
Bone Marrow Transplant; 1999 Mar; 23(6):607-12. PubMed ID: 10217192
[TBL] [Abstract][Full Text] [Related]
25. [Allogeneic bone marrow transplantation for chemotherapy-resistant T-prolymphocytic leukemia].
Okamura K; Ikeda T; Shimakura Y; Yoshiba F; Kishi K; Ando K; Hotta T
Rinsho Ketsueki; 2005 Jul; 46(7):527-31. PubMed ID: 16440747
[TBL] [Abstract][Full Text] [Related]
26. [Eradication of adult T-cell leukemia cells and maintenance of remission by the graft-versus-leukemia effect after allogeneic bone marrow transplantation].
Ota K; Hashino S; Shimizu K; Yonezumi M; Chiba K; Kondo T; Suzuki S; Imamura M; Asaka M
Rinsho Ketsueki; 2004 Sep; 45(9):1044-7. PubMed ID: 15510833
[TBL] [Abstract][Full Text] [Related]
27. Donor leukocyte infusion for Japanese patients with relapsed leukemia after allogeneic bone marrow transplantation: lower incidence of acute graft-versus-host disease and improved outcome.
Shiobara S; Nakao S; Ueda M; Yamazaki H; Takahashi S; Asano S; Yabe H; Kato S; Imoto S; Maruta A; Yoshida T; Gondo H; Morishima Y; Kodera Y
Bone Marrow Transplant; 2000 Oct; 26(7):769-74. PubMed ID: 11042659
[TBL] [Abstract][Full Text] [Related]
28. Allogeneic bone marrow transplantation from unrelated human T-cell leukemia virus-I-negative donors for adult T-cell leukemia/lymphoma: retrospective analysis of data from the Japan Marrow Donor Program.
Kato K; Kanda Y; Eto T; Muta T; Gondo H; Taniguchi S; Shibuya T; Utsunomiya A; Kawase T; Kato S; Morishima Y; Kodera Y; Harada M;
Biol Blood Marrow Transplant; 2007 Jan; 13(1):90-9. PubMed ID: 17222757
[TBL] [Abstract][Full Text] [Related]
29. [Acute monoblastic leukemia with tetrasomy 8].
Kameoka J; Horiuchi T; Miyamura K; Miura I; Okuda M; Nomura J; Hirokawa M; Sawada K; Sasaki T
Rinsho Ketsueki; 2006 Aug; 47(8):770-6. PubMed ID: 16986717
[TBL] [Abstract][Full Text] [Related]
30. Induction of a graft-versus-leukemia reaction by cyclosporin A withdrawal as immunotherapy for leukemia relapsing after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Trenn G; Schmidt O; Nahler M; Schaefer UW
Bone Marrow Transplant; 1999 Apr; 23(8):771-7. PubMed ID: 10231138
[TBL] [Abstract][Full Text] [Related]
31. Role of interleukin-12 in the development of acute graft-versus-host disease in bone marrow transplant patients.
Yabe M; Yabe H; Hattori K; Shimizu T; Matsumoto M; Morimoto T; Yasuda Y; Inoue H; Kato S; Nishimura T
Bone Marrow Transplant; 1999 Jul; 24(1):29-34. PubMed ID: 10435731
[TBL] [Abstract][Full Text] [Related]
32. Unrelated bone marrow transplantation for high-risk anaplastic large cell lymphoma in pediatric patients: a single center case series.
Cesaro S; Pillon M; Visintin G; Putti MC; Gazzola MV; D'Amore E; Scarzello G; Zanesco L; Messina C; Rosolen A
Eur J Haematol; 2005 Jul; 75(1):22-6. PubMed ID: 15946306
[TBL] [Abstract][Full Text] [Related]
33. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
34. Successful second allogeneic peripheral blood stem cell transplantation and donor lymphocyte infusion in patients with relapsed acute leukemia using the same donors as for the initial allogeneic bone marrow transplantation.
Ishikawa J; Maeda T; Kashiwagi H; Yoshida H; Takahashi I; Kawamoto SI; Yamada M; Kato H; Nishiura T; Tomiyama Y; Matsuzawa Y
Bone Marrow Transplant; 2003 Jun; 31(11):1057-9. PubMed ID: 12774060
[TBL] [Abstract][Full Text] [Related]
35. Immunotherapy with interleukin-2 after hematopoietic cell transplantation for hematologic malignancy.
Margolin K; Forman SJ
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S33-8. PubMed ID: 10685656
[TBL] [Abstract][Full Text] [Related]
36. Graft-versus-host disease following interleukin-2/lymphokine-activated killer (LAK) cell immunotherapy in a patient with acute myelogenous leukaemia in second complete remission: autologous LAK cells following allogeneic bone marrow transplantation are donor-derived.
Boughton BJ; Simpson AW; Phaure TA; Beatty C
Cancer Immunol Immunother; 1995 Jul; 41(1):68-70. PubMed ID: 7641221
[TBL] [Abstract][Full Text] [Related]
37. Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantation.
Lee CK; Gingrich RD; deMagalhaes-Silverman M; Hohl RJ; Joyce JK; Scott SD; Wen BC; Schlueter A
Biol Blood Marrow Transplant; 1999; 5(1):15-27. PubMed ID: 10232737
[TBL] [Abstract][Full Text] [Related]
38. Leukemic relapse in the central nervous system after allogeneic stem cell transplantation with complete remission in the bone marrow and donor-type chimerism: report of two cases.
Ohashi H; Kato C; Fukami S; Saito H; Hamaguchi M
Am J Hematol; 2005 Jun; 79(2):142-6. PubMed ID: 15929112
[TBL] [Abstract][Full Text] [Related]
39. Unrelated donor bone marrow transplantation for acute mixed lineage (myeloid and B-lymphoid lineage) leukemia in an adult with Down syndrome.
Takagi K; Yoshida A; Kinoshita K; Iwashima D; Imamaura S; Iwasaki H; Tsutani H; Ueda T
Ann Hematol; 2003 Apr; 82(4):236-40. PubMed ID: 12707727
[TBL] [Abstract][Full Text] [Related]
40. A successful second unrelated BMT (UBMT) from a different unrelated donor to treat ALL that relapsed after the initial UBMT.
Uehara T; Nakaseko C; Yokota A; Saito Y; Nishimura M
Am J Hematol; 2002 Sep; 71(1):37-40. PubMed ID: 12221672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
